Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$8.25M Sell
94,523
-548
-0.6% -$43K 0.32% 36
2025
Q1
$6.49M Sell
95,071
-17,412
-15% -$1.42M 0.26% 39
2024
Q4
$8.75M Sell
112,483
-19,677
-15% -$1.46M 0.32% 38
2024
Q3
$9.14M Sell
132,160
-11,175
-8% -$918K 0.32% 36
2024
Q2
$16.3M Buy
+143,335
New +$18.1M 0.58% 31

Other funds holding DXCM

Martin Currie's DXCM Position: Q2 2025 in Review

Martin Currie reduced its DexCom (DXCM) stake by 0.58% in Q2 2025, selling an estimated $43K and leaving 94,523 shares worth $8.25M. The position accounts for 0.32% of the portfolio, ranked #36.

Martin Currie first reported a position in DXCM in Q2 2024 and has held it in 5 quarters since. The position peaked at $16.3M in Q2 2024. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Martin Currie held 94,523 shares of DexCom worth $8.25M as of Q2 2025.
  • Martin Currie sold 548 DexCom shares in Q2 2025, an estimated $43K.
  • DexCom made up 0.32% of Martin Currie's portfolio in Q2 2025, its #36 holding.
  • Martin Currie first reported a position in DexCom in Q2 2024 and has held it in 5 quarters since.
  • Martin Currie's DexCom position peaked at $16.3M in Q2 2024.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Martin Currie's 13F filing for Q2 2025, filed 12 Aug 2025.